NO20002938D0 - Fibrinolytisk inhibitor som forseglingsmateriale - Google Patents

Fibrinolytisk inhibitor som forseglingsmateriale

Info

Publication number
NO20002938D0
NO20002938D0 NO20002938A NO20002938A NO20002938D0 NO 20002938 D0 NO20002938 D0 NO 20002938D0 NO 20002938 A NO20002938 A NO 20002938A NO 20002938 A NO20002938 A NO 20002938A NO 20002938 D0 NO20002938 D0 NO 20002938D0
Authority
NO
Norway
Prior art keywords
sealant
fibrinolytic inhibitor
fibrinolytic
inhibitor
Prior art date
Application number
NO20002938A
Other languages
English (en)
Other versions
NO20002938L (no
Inventor
Stewart A Cederholm-Williams
Original Assignee
Bristol Myers Squibb Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol Myers Squibb Co filed Critical Bristol Myers Squibb Co
Publication of NO20002938D0 publication Critical patent/NO20002938D0/no
Publication of NO20002938L publication Critical patent/NO20002938L/no

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L31/00Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
    • A61L31/04Macromolecular materials
    • A61L31/043Proteins; Polypeptides; Degradation products thereof
    • A61L31/046Fibrin; Fibrinogen
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/36Blood coagulation or fibrinolysis factors
    • A61K38/363Fibrinogen
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L24/00Surgical adhesives or cements; Adhesives for colostomy devices
    • A61L24/04Surgical adhesives or cements; Adhesives for colostomy devices containing macromolecular materials
    • A61L24/043Mixtures of macromolecular materials
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L24/00Surgical adhesives or cements; Adhesives for colostomy devices
    • A61L24/04Surgical adhesives or cements; Adhesives for colostomy devices containing macromolecular materials
    • A61L24/10Polypeptides; Proteins
    • A61L24/106Fibrin; Fibrinogen
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/04Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Surgery (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Hematology (AREA)
  • Engineering & Computer Science (AREA)
  • Vascular Medicine (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Zoology (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Diabetes (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Materials For Medical Uses (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
NO20002938A 1997-12-09 2000-06-08 Fibrinolytisk inhibitor som forseglingsmateriale NO20002938L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US6965297P 1997-12-09 1997-12-09
PCT/US1998/026059 WO1999029338A1 (en) 1997-12-09 1998-12-09 Fibrinolytic inhibitor for sealant

Publications (2)

Publication Number Publication Date
NO20002938D0 true NO20002938D0 (no) 2000-06-08
NO20002938L NO20002938L (no) 2000-08-08

Family

ID=22090369

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20002938A NO20002938L (no) 1997-12-09 2000-06-08 Fibrinolytisk inhibitor som forseglingsmateriale

Country Status (7)

Country Link
US (1) US6492494B1 (no)
EP (1) EP1037659A4 (no)
JP (1) JP2001525373A (no)
AU (1) AU1808999A (no)
CA (1) CA2313405A1 (no)
NO (1) NO20002938L (no)
WO (1) WO1999029338A1 (no)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6965014B1 (en) 1996-01-16 2005-11-15 Baxter International Inc. Fibrin material and method for producing and using the same
US6599515B1 (en) 1995-01-16 2003-07-29 Baxter International Inc. Fibrin porous structure
US7276235B2 (en) 1998-11-18 2007-10-02 Zlb Behring Gmbh Tissue glue with improved antiadhesive properties
DE10025001A1 (de) * 2000-05-22 2001-11-29 Aventis Behring Gmbh Gewebekleber mit verbesserten anti-adhäsiven Eigenschaften
EP1695724B1 (en) * 2001-05-09 2018-01-24 Baxter International Inc. Fibrin material and method for producing and using the same
EP1387703B1 (en) * 2001-05-09 2006-07-26 Baxter International Inc. Fibrin material and method for producing and using the same
JP2005510516A (ja) * 2001-11-09 2005-04-21 ノボ ノルディスク ヘルス ケア アクチェンゲゼルシャフト Vii因子ポリペプチドおよびプロテインs阻害剤を含む薬学的組成物
EP1603601A1 (en) * 2003-02-20 2005-12-14 Hamilton Civic Hospitals Research Development, Inc. Coating composition for polymeric surfaces comprising serpin or serpin derivatives
US20070042015A1 (en) * 2003-02-20 2007-02-22 Berry Leslie R Coating composition for polymeric surfaces comprising serpin or serpin derivatives
DE102005003145B4 (de) * 2005-01-21 2006-10-19 Dade Behring Marburg Gmbh Stablies, chromogenes Flüssigreagenz und dessen Verwendung in gerinnungsdiagnostischen Tests
US8414907B2 (en) 2005-04-28 2013-04-09 Warsaw Orthopedic, Inc. Coatings on medical implants to guide soft tissue healing
US9119901B2 (en) 2005-04-28 2015-09-01 Warsaw Orthopedic, Inc. Surface treatments for promoting selective tissue attachment to medical impants
WO2010129258A2 (en) 2009-04-27 2010-11-11 Mallinckrodt Inc. Tissue sealant compositions, vascular closure devices, and uses thereof
US8999376B2 (en) 2012-02-03 2015-04-07 Xcede Technologies, Inc. Tissue patch
US9833538B2 (en) 2015-08-07 2017-12-05 Xcede Technologies, Inc. Adhesive compositions and related methods
CA2994959A1 (en) 2015-08-07 2017-02-16 Xcede Technologies, Inc. Adhesive compositions and related methods
US9540548B1 (en) 2015-08-07 2017-01-10 Xcede Technologies, Inc. Adhesive compositions and related methods

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4442655A (en) * 1981-06-25 1984-04-17 Serapharm Michael Stroetmann Fibrinogen-containing dry preparation, manufacture and use thereof
EP0068047B1 (de) * 1981-06-25 1986-07-23 Serapharm GmbH & Co. KG Angereichertes Plasmaderivat zur Unterstützung von Wundverschluss und Wundheilung
US5226877A (en) * 1989-06-23 1993-07-13 Epstein Gordon H Method and apparatus for preparing fibrinogen adhesive from whole blood
CN1091315A (zh) * 1992-10-08 1994-08-31 E·R·斯奎布父子公司 血纤维蛋白封闭剂组合物及其使用方法
US5464471A (en) * 1994-11-10 1995-11-07 Whalen Biomedical Inc. Fibrin monomer based tissue adhesive
BR9509860A (pt) * 1994-12-02 1997-09-30 Squibb & Sons Inc Sistema de distribuição de reagente em centrífuga
CN1207688A (zh) * 1995-12-07 1999-02-10 布里斯托尔-迈尔斯斯奎布公司 施加两种液体组份的混合物的方法

Also Published As

Publication number Publication date
NO20002938L (no) 2000-08-08
AU1808999A (en) 1999-06-28
EP1037659A4 (en) 2005-02-09
JP2001525373A (ja) 2001-12-11
CA2313405A1 (en) 1999-06-17
WO1999029338A1 (en) 1999-06-17
EP1037659A1 (en) 2000-09-27
US6492494B1 (en) 2002-12-10

Similar Documents

Publication Publication Date Title
DE69809982D1 (de) Dichtungszusammensetzungen
NO992821D0 (no) Ketobenzamider som calpain-inhibitorer
ATE249979T1 (de) Abgabedichtung
BR9801675A (pt) Vedação
NO20002938L (no) Fibrinolytisk inhibitor som forseglingsmateriale
FI973537A (fi) Pakkaaminen
PT1047450E (pt) Combinacoes inibidor ace - inibidor mmp
NO995434L (no) Proteaseinhibitorer
DK0975623T3 (da) Indazolamidforbindelser som sertoninerge midler
NO994103D0 (no) Reverse hydroksamatderivater som metallproteaseinhibitorer
DK0924250T3 (da) Latexforseglingsmidler indeholdende epoxysilaner
NO995435D0 (no) Protease-inhibitorer
AU8858398A (en) Matrix metalloproteinase inhibitors
NO995268D0 (no) Proteaseinhibitorer
DE69832237D1 (de) Abdichtung
NO20001924D0 (no) Isoquinoliner som urokinase-inhibitorer
DE59804343D1 (de) Schraubwerkzeug
DE69822736D1 (de) Hochdruckdichtung
NO993583L (no) Tetningsanordning
NO996046D0 (no) Blandinger nyttige som fibrin forsegling
AU9747098A (en) Aporphinoid matrix metalloproteinase inhibitors
NO995984D0 (no) Tetningsanordning
DK199900970A (da) Tætningsarrangement
DE59708948D1 (de) Dichtring
SE9700715D0 (sv) Flaska som byggelement

Legal Events

Date Code Title Description
CREP Change of representative

Representative=s name: BRYN AARFLOT AS, POSTBOKS 449 SENTRUM, 0104 OSLO,

FC2A Withdrawal, rejection or dismissal of laid open patent application